Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Proluton and Cyclogest on Perinatal Outcome
IRCT20181107041585N4Phase 2Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of hydroxyprogesterone caproate and progesterone in preterm birth, sponsored by Hormozgan University of Medical Sciences. Started May 2017; status: completed.
02
Drugs
hydroxyprogesterone caproateprogesterone
03
Conditions
preterm birth
Beyond the preview
Go deeper on IRCT20181107041585N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181107041585N4.